A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

Clinical trial NCT07070076 · RECRUITING

Trial details

NCT number: NCT07070076
Sponsor: Li Qiang
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2026-08-01
Primary completion: 2030-08-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.